Science & Enterprise subscription

Follow us on Twitter

  • Researchers from University of California in Los Angeles and Apple Corp. are beginning a study of wearable and home… https://t.co/ICUkzqP2sH
    about 2 hours ago
  • New post on Science and Enterprise: UCLA, Apple Partner on Depression Study https://t.co/6JcVfww7FT #Science #Business
    about 2 hours ago
  • A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is ra… https://t.co/LFNVxych8d
    about 8 hours ago
  • New post on Science and Enterprise: New Allergy Biotech Launches, Raises $10M https://t.co/x5W0TwnCBu #Science #Business
    about 8 hours ago
  • Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 inf… https://t.co/LaUrUiRmhk
    about 1 day ago

Please share Science & Enterprise

NIH Issues Contracts for Faster Covid-19 Diagnostics

Accula SARS-CoV-2 test

National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays. . . . → Read More: NIH Issues Contracts for Faster Covid-19 Diagnostics

NIH Expands Covid-19 Test Technology Challenge

Covid-19 testing

National Institutes of Health is expanding its challenge competition to make tests for Covid-19 viruses more widely available and return results faster. . . . → Read More: NIH Expands Covid-19 Test Technology Challenge

Immune Responses Shown in Covid-19 Nasal Vaccine

Nasal spray

An experimental vaccine to prevent Covid-19 infections, given as a nasal spray, produces immune responses in tests with lab mice. . . . → Read More: Immune Responses Shown in Covid-19 Nasal Vaccine

BARDA to Buy $2B in Covid-19 Vaccines, Therapies

Syringe, pills, capsules

The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines and treatments now in clinical trials. . . . → Read More: BARDA to Buy $2B in Covid-19 Vaccines, Therapies

FDA Halts Off-the-Shelf Engineered T-Cell Trial

Stop sign

A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple myeloma when a patient in the trial died. . . . → Read More: FDA Halts Off-the-Shelf Engineered T-Cell Trial

Polymer Boosts Insulin Speed, Stability

Drug vials

Researchers discovered a polymer compound added to insulin that in tests with pigs cuts insulin’s acting time in half and more than doubles its usable life. . . . → Read More: Polymer Boosts Insulin Speed, Stability

FDA Sets Review Criteria for Covid-19 Vaccines

Syringes

The Food and Drug Administration issued its standards that developers need to meet in evidence submitted for review of vaccines to prevent Covid-19 infections. . . . → Read More: FDA Sets Review Criteria for Covid-19 Vaccines

Open-Source N95 Respirator Mask in the Works

Open source N95 mask

An engineering partnership is designing a 3-D printed medical face mask needed by front-line health care workers, with its specifications soon to be made freely available. . . . → Read More: Open-Source N95 Respirator Mask in the Works

Gut Microbe Drug Shown to Prevent Return Infections

C. difficile in petri dish

Early results from a clinical trial show an oral drug taken one time prevents more recurring infections from harmful gut bacteria than conventional treatments. . . . → Read More: Gut Microbe Drug Shown to Prevent Return Infections

Covid-19 Dual Therapy Drug Trial Okayed

SARS-Cov-2 viruses

A company developing an oral drug that treats both Covid-19 infections and overactive immune system reactions received regulatory approval for a later-stage clinical trial. . . . → Read More: Covid-19 Dual Therapy Drug Trial Okayed